Document Detail


Utilization of blood spot testing for metabolic-genetic disorders in Honduras: is it time for newborn screening?
MedLine Citation:
PMID:  19850562     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Honduran infant mortality (20/1000) has fallen below the Latin American newborn screening target rate (<30/1000). The authors report 2 Honduran maple syrup urine disease cases and a newborn screening pilot study. The first infant, diagnosed by plasma/urine testing in the U.S., prompted this study. Although marked clinical/radiological improvement occurred after treatment, moderate neurodevelopmental delays persist at 5 years. This 1-month, prospective study used blood spot specimens from hospitalized term Honduran neonates shipped overnight to South Carolina for routine newborn screening with electronic result submission to Honduras for follow-up. Of 88 consecutive neonates (mean age: 4.2 days, standard deviation: 4.2 days) tested, 24 (0.6%) of 3837 completed tests were positive. Another infant with maple syrup urine disease, diagnosed after study completion by blood spot testing, later died. The study findings indicate that collaborative blood spot testing aids in the diagnosis of Honduran metabolic-genetic disease. Newborn screening is now needed to diagnose and treat these diseases before morbidity/mortality develops.
Authors:
Jonathan L Slaughter; Lesby Espinoza; Isaac Molinero; Tim C Wood; Carlos Duron; Armando Flores; Robyn Porter; Kathy Tomashitis; Kenton R Holden
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2009-10-21
Journal Detail:
Title:  Journal of child neurology     Volume:  25     ISSN:  1708-8283     ISO Abbreviation:  J. Child Neurol.     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-03-01     Completed Date:  2010-06-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8606714     Medline TA:  J Child Neurol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  306-11     Citation Subset:  IM    
Affiliation:
Division of Neonatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA. Jonathan.Slaughter@cchmc.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blood Chemical Analysis* / economics,  methods
Blood Specimen Collection
Fatal Outcome
Follow-Up Studies
Honduras
Humans
Infant, Newborn
Male
Maple Syrup Urine Disease / blood,  diagnosis*,  therapy
Neonatal Screening* / economics,  methods
Pilot Projects
South Carolina
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Circulatory Arrest in a Brain-Dead Organ Donor: Is the Use of Cardiac Compression Permissible?
Next Document:  Recovery from spatial neglect and hemiplegia in a child despite a large anterior circulation stroke ...